Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 1 hour 10 min ago

Aralez Receives Health Canada Approval For BLEXTEN(TM)

Mon, 04/25/2016 - 13:34
MILTON, Ontario, April 25, 2016 -- (Healthcare Sales & Marketing Network) -- Aralez Pharmaceuticals Inc. (ARLZ) (ARZ.TO) ("Aralez" or the "Company"), a global specialty pharmaceutical company, today announced the Health Canada approva...
Biopharmaceuticals, Regulatory
Aralez Pharmaceuticals, BLEXTEN, bilastine, Seasonal Allergic Rhinitis

Celator(R) Pharmaceuticals Announces Positive Results Demonstrating Reduced Healthcare Resource Use with VYXEOS(TM) Compared to Standard Treatment for Acute Myeloid Leukemia (AML)

Mon, 04/25/2016 - 13:24
Phase 2 study results presented at the Academy of Managed Care Pharmacy (AMCP) Annual Meeting EWING, N.J., April 25, 2016 -- (Healthcare Sales & Marketing Network) -- Celator Pharmaceuticals, Inc. (CPXX) today announced that patients treated in a Phase...
Biopharmaceuticals, Oncology
Celator Pharmaceuticals, VYXEOS, acute myeloid leukemia

Pharnext Announces the Opening of the First U.S. Study Site for its PLEO-CMT International Pivotal Phase 3 Trial in Charcot-Marie-Tooth Disease Type 1A

Mon, 04/25/2016 - 13:13
PARIS, April 25, 2016 -- (Healthcare Sales & Marketing Network) -- Pharnext today announced the opening of the first U.S. trial site for its PLEO-CMT pivotal Phase 3 clinical trial of its lead pleodrug PXT3003 in Charcot-Marie-Tooth Disease Type 1A (CMT1A...
Biopharmaceuticals
Pharnext, PLEO-CMT, Pleotherapy, Charcot-Marie-Tooth

Elekta to Demonstrate Market-leading Radiosurgery Solutions and Innovations at ESTRO 35

Mon, 04/25/2016 - 13:05
TURIN, Italy, April 25, 2016 -- (Healthcare Sales & Marketing Network) -- ESTRO Booths 200 and 500 - At ESTRO 35 (April 29 - May 3, at Lingotto Fiere in Turin), Elekta will demonstrate a full range of radiotherapy planning and delivery solutions, includin...
Devices, Oncology, Neurosurgery
Elekta, radiotherapy, Leksell, Gamma Knife, radiosurgery

Fiagon Receives FDA Clearance For Brain Surgery

Fri, 04/22/2016 - 16:09
BERLIN, April 22, 2016 -- (Healthcare Sales & Marketing Network) -- Fiagon AG medical technologies announced today that it received U.S. Food and Drug Administration (FDA) 510k clearance for its brain navigation software. The clearance includes the compan...
Devices, Neurosurgery, FDA
Fiagon AG, brain navigation, BiopsyPointer, FlexPointer, ShuntPointer

BioMmune Appoints Dr. Patrick Gray as New Chief Executive Officer and President

Fri, 04/22/2016 - 13:48
VANCOUVER, BRITISH COLUMBIA--(Healthcare Sales & Marketing Network) - BioMmune Technologies Inc. ("BioMmune" or the "Company") (TSX VENTURE:IMU), a company focused on harnessing the body's immune system to fight cancer and autoimmune di...
Biopharmaceuticals, Personnel
BioMmune Technologies

Accuray Hosts Regional AERO Users' Meeting

Fri, 04/22/2016 - 13:40
Leading Oncology Specialists Discuss Best Practices and Innovations in Cancer Treatment SUNNYVALE, Calif., April 22, 2016 -- (Healthcare Sales & Marketing Network) -- Accuray Incorporated (ARAY) announced today that the Accuray Exchange in Radiation On...
Devices, Oncology
Accuray, CyberKnife, TomoTherapy,

Symic Appoints Kathleen Gogas, Ph.D., as VP of Preclinical Development

Thu, 04/21/2016 - 18:02
Dr. Gogas brings over 20 years of industry experience to the company SAN FRANCISCO, April 21, 2016 -- (Healthcare Sales & Marketing Network) -- Symic, a clinical-stage biotherapeutics company developing multiple compounds that target the extracellular ...
Biopharmaceuticals, Personnel
Symic, extracellular matrix

Abbott Introduces New Services and Tools to Help Labs Deliver Greater Operational Productivity

Thu, 04/21/2016 - 17:56
ALINIQ, A NEW PROFESSIONAL SERVICES AND INFORMATICS PORTFOLIO, IS NOW AVAILABLE WORLDWIDE ABBOTT PARK, Ill., April 21, 2016 -- (Healthcare Sales & Marketing Network) -- Abbott (ABT) today announced the global launch of AlinIQ, the first in a series of ...
Diagnostics, Product Launch
Abbott, AlinIQ

eNeura, Inc. Receives CE Mark Label Extension Expanding Use of SpringTMS(R) to Include Migraine Prevention

Thu, 04/21/2016 - 15:07
SpringTMS is now available to patients in the United Kingdom for acute treatment of migraine and migraine prevention BALTIMORE, April 21, 2016 -- (Healthcare Sales & Marketing Network) -- eNeura, Inc., a privately held medical technology company, annou...
Devices, Neurology, Regulatory
eNeura, SpringTMS, migraine, Transcranial Magnetic Stimulation

FDA Grants Orphan Drug Designation For VAL-083 In Ovarian Cancer

Thu, 04/21/2016 - 15:03
New Orphan Designation is the Third Awarded to DelMar Pharmaceuticals by FDA Office of Orphan Products Development (OOPD) VANCOUVER, British Columbia and MENLO PARK, Calif., April 21, 2016 -- (Healthcare Sales & Marketing Network) -- DelMar Pharmaceuti...
Biopharmaceuticals, Oncology, FDA
DelMar Pharmaceuticals, VAL-083, ovarian cancer

Hologic Announces FDA Clearance and Commercial Availability of the Affirm(TM) Prone Biopsy System, the First 2D/3D(TM) Imaging-Guided Dedicated Prone Biopsy System

Thu, 04/21/2016 - 15:01
New System Pairs 360-Degree Breast Access with Exceptional 2D/3D™ Biopsy Imaging MARLBOROUGH, Mass., April 21, 2016 -- (Healthcare Sales & Marketing Network) -- Hologic, Inc. (HOLX) today announced the U.S. Food and Drug Administration (FDA) clearance ...
Devices, Oncology, Radiology, FDA, Product Launch
Hologic, prone biopsy

BD Divests Vertebral Augmentation Solutions Business to Stryker

Thu, 04/21/2016 - 14:55
FRANKLIN LAKES, N.J., April 21, 2016 -- (Healthcare Sales & Marketing Network) -- BD (Becton, Dickinson and Company) (BDX), a leading medical technology company, announced today that it has sold its vertebral augmentation solutions business, which include...
Devices, Orthopaedic, Neurosurgery, Acquisitions
BD, Stryker, AVAmax, AVAflex, AVAtex, AVAprep

Second Genome Secures $42.6 Million in Series B Financing Led by Pfizer Venture Investments and Roche Venture Fund

Wed, 04/20/2016 - 15:29
Financing to expand the Second Genome Microbiome Discovery Platform and accelerate the clinical development of pipeline programs SOUTH SAN FRANCISCO, Calif., April 20, 2016 -- (Healthcare Sales & Marketing Network) -- Second Genome, Inc., a privately-h...
Biopharmaceuticals, Venture Capital, Personnel
Second Genome, microbiome

Boston Scientific Announces CE Mark For MRI Labeling Of Emblem(TM) S-ICD Systems

Wed, 04/20/2016 - 13:30
European Approval Granted for Third-Generation System and All Previously Implanted, Second-Generation Systems MARLBOROUGH, Mass., April 20, 2016 -- (Healthcare Sales & Marketing Network) -- Boston Scientific (BSX) has received CE Mark approval for the ...
Devices, Cardiology, Regulatory
Boston Scientific, EMBLEM MRI, Subcutaneous Implantable Defibrillator, ICD

Oculus Innovative Sciences Receives U.S. FDA Approval for Lasercyn(TM) for Use Following Laser Procedures, Microdermabrasions and Chemical Peels

Wed, 04/20/2016 - 13:23
PETALUMA, Calif., April 20, 2016 -- (Healthcare Sales & Marketing Network) -- Oculus Innovative Sciences, Inc. (NASDAQ: OCLS, warrants OCLSW), a specialty pharmaceutical company that develops and markets solutions for the treatment of dermatological condit...
Biopharmaceuticals, Dermatology, FDA
Oculus Innovative Sciences, Microcyn, Lasercyn Gel

Alma Surgical to Launch the 2nd Generation Femilift, the Femilift Smart, a New Robotic Probe for Advanced Precision and Faster Treatment of Feminine Health Concerns

Wed, 04/20/2016 - 13:17
The FemiLift Smart, a New Robotic Probe for Homogeneous & Faster Treatments ROME, April 20, 2016 -- (Healthcare Sales & Marketing Network) -- Alma Surgical, a division of Alma Lasers, a global innovator of laser, light-based, radiofrequency and ultraso...
Devices, Product Launch
Alma Surgical, Alma Lasers, FemiLift Smart

Enterome Raises EUR14.5 Million in Series C Financing Round

Wed, 04/20/2016 - 13:09
Nestlé Health Science Invests Alongside Existing Investors PARIS and BOSTON, April 20, 2016 -- (Healthcare Sales & Marketing Network) -- ENTEROME Bioscience SA, a pioneer in the development of pharmaceuticals and diagnostics based on the gut mic...
Biopharmaceuticals, Gastroenterology, Venture Capital
Enterome Bioscience, gut microbiome, inflammatory bowel disease

John Lapré to Fulfill Role as Elekta’s Chief Technology Officer

Wed, 04/20/2016 - 13:02
STOCKHOLM--(Healthcare Sales & Marketing Network)--In order to further strengthen its innovation leadership, Elekta (EKTA-B.ST) announced today the appointment of John Lapré as Chief Technology Officer, effective May 1, 2016. John Lapré sa...
Devices, Oncology, Neurosurgery, Personnel
Elekta, Leksell, Gamma Knife, radiosurgery, radiotherapy

Caltorque Medical Products Expands Portfolio of Cost Responsible(SM) Surgical Instruments

Tue, 04/19/2016 - 17:30
Orthopedic Medical Device OEM's access the most Robust, Diverse Featured and reliable Single Procedure, Multiple Procedure and instrument portfolio at significant cost responsible(sm) pricing Chino, CA -- (Healthcare Sales & Marketing Network) -- Caltor...
Devices, Surgery, Product Launch
Caltorque Medical Products

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong